STLN
The Oncology Institute, Inc.
6.60$
+7.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| -0.06 | -0.11 | -0.13 | 0.03 | -0.02 | 0.12 | 0.00 | |
| 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.07 | |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.05 | |
| 0.04 | -0.04 | -0.06 | 0.08 | 0.01 | 0.14 | 0.16 | |
| 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | |
| – | – | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | |
| -0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.05 | 0.02 | 0.11 | 0.04 | 0.00 | 0.00 | 0.14 | |
| -0.11 | -0.10 | -0.03 | 0.06 | -0.03 | 0.10 | 0.10 | |
| -0.06 | -0.12 | -0.14 | 0.02 | -0.03 | 0.11 | -0.03 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.